1. Home
  2. CTKB vs AMAL Comparison

CTKB vs AMAL Comparison

Compare CTKB & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • AMAL
  • Stock Information
  • Founded
  • CTKB 1990
  • AMAL 1923
  • Country
  • CTKB United States
  • AMAL United States
  • Employees
  • CTKB N/A
  • AMAL N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AMAL Commercial Banks
  • Sector
  • CTKB Health Care
  • AMAL Finance
  • Exchange
  • CTKB Nasdaq
  • AMAL Nasdaq
  • Market Cap
  • CTKB 697.0M
  • AMAL 761.0M
  • IPO Year
  • CTKB 2021
  • AMAL 2018
  • Fundamental
  • Price
  • CTKB $5.30
  • AMAL $30.93
  • Analyst Decision
  • CTKB Buy
  • AMAL Buy
  • Analyst Count
  • CTKB 4
  • AMAL 3
  • Target Price
  • CTKB $8.50
  • AMAL $32.17
  • AVG Volume (30 Days)
  • CTKB 517.4K
  • AMAL 119.5K
  • Earning Date
  • CTKB 08-06-2024
  • AMAL 10-24-2024
  • Dividend Yield
  • CTKB N/A
  • AMAL 1.55%
  • EPS Growth
  • CTKB N/A
  • AMAL 10.19
  • EPS
  • CTKB N/A
  • AMAL 3.22
  • Revenue
  • CTKB $197,711,000.00
  • AMAL $292,029,000.00
  • Revenue This Year
  • CTKB $8.13
  • AMAL N/A
  • Revenue Next Year
  • CTKB $15.93
  • AMAL $5.35
  • P/E Ratio
  • CTKB N/A
  • AMAL $9.60
  • Revenue Growth
  • CTKB 12.60
  • AMAL 8.84
  • 52 Week Low
  • CTKB $3.80
  • AMAL $15.19
  • 52 Week High
  • CTKB $9.87
  • AMAL $33.24
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.03
  • AMAL 50.57
  • Support Level
  • CTKB $5.20
  • AMAL $31.62
  • Resistance Level
  • CTKB $5.50
  • AMAL $33.24
  • Average True Range (ATR)
  • CTKB 0.23
  • AMAL 0.78
  • MACD
  • CTKB 0.00
  • AMAL -0.07
  • Stochastic Oscillator
  • CTKB 16.95
  • AMAL 32.46

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About AMAL Amalgamated Financial Corp. (DE)

Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers a range of products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.

Share on Social Networks: